Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of GoodwillAmortization of GoodwillAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt repayments
Ratios

Avanos Medical (AVNS) Shares Issued (2016 - 2026)

Avanos Medical's Shares Issued history spans 11 years, with the latest figure at $300000.0 for Q3 2025.

  • On a quarterly basis, Shares Issued fell 50.0% to $300000.0 in Q3 2025 year-over-year; TTM through Dec 2025 was $700000.0, a 36.36% decrease, with the full-year FY2025 number at $700000.0, down 36.36% from a year prior.
  • Shares Issued hit $300000.0 in Q3 2025 for Avanos Medical, down from $400000.0 in the prior quarter.
  • Over the last five years, Shares Issued for AVNS hit a ceiling of $4.8 million in Q1 2021 and a floor of -$200000.0 in Q4 2023.
  • Historically, Shares Issued has averaged $778571.4 across 5 years, with a median of $550000.0 in 2023.
  • Biggest five-year swings in Shares Issued: grew 12.5% in 2021 and later plummeted 300.0% in 2023.
  • Tracing AVNS's Shares Issued over 5 years: stood at $900000.0 in 2021, then plummeted by 88.89% to $100000.0 in 2022, then plummeted by 300.0% to -$200000.0 in 2023, then surged by 400.0% to $600000.0 in 2024, then crashed by 50.0% to $300000.0 in 2025.
  • Business Quant data shows Shares Issued for AVNS at $300000.0 in Q3 2025, $400000.0 in Q1 2025, and $600000.0 in Q3 2024.